Mankind Pharma Ltd Share Price

Pharmaceuticals - Indian - Bulk Drugs & Formln Lrg

NSE: MANKIND Large Cap ISIN: INE634S01028
As on 22 December 2024 at 23:29 IST
As on 22 December 2024 at 23:29 IST
2,891.05
+ 85.10
(3.03%)
Over 1 Month
9.64%
Over 6 Months
27.74%
Over 1 Year
48.98%
Over 3 Years
0.00%

Mankind Pharma Ltd Summary

Close 2,891.05
Open 2,775.10
High 2,922.90
Low 2,744.20
Volume 13,91,363
Net Turnover (in ₹) 1,90,44,32,844.20
52 Week High 2,922.90
52 Week Low 1,851.05
52Wk High / Low
1,851.05
2,922.90

Mankind Pharma Ltd Key Financial Data

Market Cap (in ₹ Cr) 1,12,393.74
EPS (TTM) 50.03
Book Value (BV) 269.24
Div. Yield -
P/E (TTM) 53.77
Price/Book Value 10.41
Delivery % 41.45
Face Value 1

Mankind Pharma Ltd Key Ratios

P/E ratio 50.47
P/B ratio 9.56
EV to Sales 9.85
PEG Ratio 1.10
ROA 18.69
ROE 20.95
Debt-Equity -
Net Profit Margin 19.68
Operating Profit Margin 27.98

Mankind Pharma Ltd Peer Comparison

Company LTP Market Cap (in ₹ Cr)
Mankind Pharma Ltd ₹2,803.45 ₹1,12,323.63
Sun Pharmaceuticals Industries Ltd ₹1,808.50 ₹4,33,919.73
Divis Laboratories Ltd ₹5,844.75 ₹1,55,159.75
Cipla Ltd ₹1,472.45 ₹1,18,917.13
Torrent Pharmaceuticals Ltd ₹3,434.25 ₹1,16,225.41
Dr Reddys Laboratories Ltd ₹1,342.45 ₹1,12,015.49

Mankind Pharma Ltd News

Mankind Pharma allots 1.19 cr equity shares under QIP issue

20 Dec 2024

Mankind Pharma raises nearly Rs 3,000 crore from eligible institutional buyers via QIP issue

Mankind Pharma said that its board has approved the closure of the issue for the qualified institutions placement of equity shares of the company on Thursday, 19 December 2024.

20 Dec 2024

Mankind Pharma edges higher after board approves opening of Rs 3,000 crore QIP issue

Mankind Pharma added 1.17% to Rs 2722.15 after the company informed that its board has approved the opening of issue of qualified institutional placement (QIP) of equity shares with the floor price of Rs 2,616.55 per equity share.

17 Dec 2024

Mankind Pharma Ltd rises for third consecutive session

Mankind Pharma Ltd is quoting at Rs 2609.95, up 1.9% on the day as on 12:49 IST on the NSE. The stock is up 35.66% in last one year as compared to a 16.91% spurt in NIFTY and a 38.53% spurt in the Nifty Pharma index.

02 Dec 2024

Mankind Pharma Ltd slips for fifth straight session

Mankind Pharma Ltd is quoting at Rs 2537.6, down 3.22% on the day as on 12:59 IST on the NSE. The stock jumped 23.9% in last one year as compared to a 20.25% rally in NIFTY and a 40.48% spurt in the Nifty Pharma index.

13 Nov 2024

Mankind Pharma Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Total Revenue9,531.458,289.947,690.045,677.684,888.26
Total Expenses7,271.886,727.105,818.604,237.473,623.34
Profit Before Tax2,259.571,562.841,871.441,440.211,264.92
Profit After Tax1,823.411,248.261,389.421,084.37958.23
Operating Profit after Depreciation2,274.141,590.581,918.561,448.191,275.54

Balance Sheet

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Fixed Assets3,473.773,193.852,952.58982.01942.95
Total Non Current Assets5,927.305,854.215,122.992,790.352,582.50
Total Current Assets5,490.413,516.913,815.713,089.981,948.60
TOTAL ASSETS11,417.719,371.128,938.705,880.334,531.11
Total Shareholder's Fund9,623.817,783.916,540.454,734.273,651.45

Cash Flow

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Net Cash from Operating Activities1,982.971,798.99821.44983.38959.61
Net Cash used in Investing Activities-1,919.22-1,040.61-1,360.27-1,127.16-395.68
Net Cash used in Financing Activities-8.68-710.41578.6388.87-558.91

Mankind Pharma Ltd Corporate Actions

No available data

About Mankind Pharma Ltd

Mankind Pharma Ltd is a prominent pharmaceutical company in India. It is engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations. The company operates in various therapeutic areas, including antibiotics and erectile dysfunction medications. Additionally, Mankind Pharma has a strong presence in the consumer healthcare segment. Its products include condoms, pregnancy detection kits, and emergency contraceptives.

Mankind Pharma falls under the pharmaceutical sector. The company was incorporated in 1991 and began its operations in 1995. Over the years, it has grown to become one of the top pharmaceutical companies in India, known for its commitment to quality and affordability.

The headquarters of Mankind Pharma is located in Okhla Phase III, New Delhi, India. The promoters of the company include Ramesh Juneja Family Trust, with a 20.80% stake. A team of managerial promoters manage the operations of the company. They are
  • Rajeev Juneja
  • Sheetal Arora
  • Satish Kumar Sharma
  • Vivek Kalra

Mankind Pharma's main products include a wide range of pharmaceuticals and consumer healthcare products. Some of its well-known brands include Manforce (condoms), Prega News (pregnancy detection kits), and Unwanted-72 (emergency contraceptive pills). It also offers prescription medications such as Telmikind, Moxikind-CV, and Nurokind. The company also manufactures over-the-counter products.

Mankind Pharma is a leading player in the pharmaceutical industry. Still, it is not the largest in terms of market share or capitalization. However, it is recognized for its strong market presence and innovative products. The company has a market capitalization of approximately ₹1.082 trillion. This makes it one of the most valuable pharmaceutical companies in India. The registered office of Mankind Pharma Ltd is in Okhla Industrial Estate, New Delhi. Meanwhile the office of the registrars is in Hyderabad, Telangana.

The vision of Mankind Pharma Limited

Mankind Pharma Ltd envisions a future where high-quality healthcare is accessible and affordable to all. The company's vision is to become a global pharmaceutical leader. It aims to be admired for its commitment to the affordability and accessibility of its products.

The company aims to provide cost-effective pharmaceutical products that improve the lives of patients. Mankind Pharma focuses on innovation to develop superior-quality medications. This commitment to innovation allows the company to meet the growing needs of society. It also helps provide solutions for various health challenges.

Mankind Pharma's vision includes a strong emphasis on quality. The company believes that maintaining high standards of quality is essential for building trust with its customers. This focus on quality is reflected in every aspect of the company's operations, from research and development to manufacturing and distribution. Mankind Pharma strives to deliver products that meet the highest standards of safety and efficacy.

Accessibility is another key component of Mankind Pharma's vision. The company aims to make its products available across different geographic regions. This includes expanding its presence in rural and underserved areas where access to healthcare is often limited. Mankind Pharma believes that making its products widely available can help bridge the gap in healthcare access. This, in turn, can improve the overall health of communities.

The company's vision also includes a commitment to sustainability. Mankind Pharma is dedicated to operating in an environmentally responsible manner. This includes implementing sustainable business practices and supporting initiatives that promote environmental conservation.

Mankind Pharma's vision is supported by a strong corporate culture that values integrity and accountability. The company believes that adhering to these principles is essential for building trust with its customers and stakeholders. This trust is crucial for achieving the company's long-term goals and sustaining its growth.

The company also places a strong emphasis on customer-centricity. Mankind Pharma strives to understand the needs of its customers and provide personalized solutions. This customer-centric approach enables the company to build strong relationships with its customers. It also helps deliver products that meet their specific needs.

Mankind Pharma's vision includes a focus on continuous improvement. The company is committed to constantly enhancing its products and services. This includes investing in research and development to develop new and innovative solutions.

The company's vision is also aligned with its mission to improve the quality of life for patients. Mankind Pharma aims to provide medications that help people lead healthier lives. This includes developing treatments for various acute and chronic conditions. The company believes that improving the health of individuals can have a positive impact on society as a whole.

Mankind Pharma's vision extends beyond its products and services. The company is actively involved in corporate social responsibility (CSR) initiatives. These initiatives focus on areas such as health, education, and community development. Mankind Pharma believes that giving back to society is an important part of its vision and mission.

The company's vision is also reflected in its strategic priorities. These include expanding its global presence and improving its operational efficiency. Mankind Pharma aims to achieve these goals by leveraging its strengths and capitalizing on opportunities in the market.

A dedicated team of professionals supports Mankind Pharma's vision. The company's employees are committed to achieving its vision and mission. Mankind Pharma believes that investing in its people is essential for driving innovation and achieving its strategic objectives.

Mankind Pharma Ltd Stock Analysis

  1. Annual revenue for Mankind Pharma Ltd increased by 14.98% to ₹9,531.45 crore in FY 2024 from ₹8,289.94 crore in FY 2023.
  2. Annual Net Profit for Mankind Pharma Ltd increased by 46.08% to ₹1,823.41 crore in FY 2024 from ₹1,248.26 crore in FY 2023.
  3. Promoter Shareholding in Mankind Pharma Ltd remains unchanged by 0.00% in the most recent quarter, from 74.87% in June 2024 to 74.87% in September 2024.
  4. Mankind Pharma Ltd delivered a 1-year return of 48.98% compared to the Nifty 50, which provided a return of 11.52% as of the last trading session.
  5. Mankind Pharma Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹2,891.05. The latest Mankind Pharma Ltd share price is INR ₹2,891.05.
  6. Mankind Pharma Ltd share price today has been at a low of 2,755 and a high of 2,908. Over the past 52 weeks, the Mankind Pharma Ltd share price has seen a low of 1,851.05 and a high of 2,922.90.

FAQ’s

What is the share price of Mankind Pharma Ltd today?

Mankind Pharma Ltd share price as on 22 Dec 2024 is ₹ 2891.05

What is the Market Cap of Mankind Pharma Ltd?

The market cap of Mankind Pharma Ltd stock is ₹1,12,393.74 Cr.

What is the PE Ratio of Mankind Pharma Ltd?

The Price to Earnings (P/E) Ratio of Mankind Pharma Ltd is 50.47

What is the PB Ratio of Mankind Pharma Ltd?

The Price to Book (P/B) Ratio of Mankind Pharma Ltd is 9.56

What is the 52 week high of Mankind Pharma Ltd Share Price?

The 52 week high of Mankind Pharma Ltd share price stands at ₹2,922.90

What is the 52 week low of Mankind Pharma Ltd Share Price?

The 52 week low of Mankind Pharma Ltd share price stands at ₹1,851.05

Get started with us today and
start building your wealth journey